This list is an analysis based on recent market events. It's not an investment recommendation.
As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
FAQs
What is NeoImmuneTech. stock price today?▼
The current price of 950220.KQ is ₩1,611 KRW — it has decreased by -0.43% in the past 24 hours. Watch NeoImmuneTech. stock price performance more closely on the chart.
What is NeoImmuneTech. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange NeoImmuneTech. stocks are traded under the ticker 950220.KQ.
Is NeoImmuneTech. stock price growing?▼
950220.KQ stock has fallen by -4.07% compared to the previous week, the month change is a -19.29% fall, over the last year NeoImmuneTech. has showed a -41.75% decrease.
What is NeoImmuneTech. market cap?▼
Today NeoImmuneTech. has the market capitalization of 11.02B
What is NeoImmuneTech. revenue for the last year?▼
NeoImmuneTech. revenue for the last year amounts to 94.76M KRW.
What is NeoImmuneTech. net income for the last year?▼
950220.KQ net income for the last year is -31.79B KRW.
How many employees does NeoImmuneTech. have?▼
As of November 3, 2026, the company has 82 employees.
In which sector is NeoImmuneTech. located?▼
NeoImmuneTech. operates in the Health & Wellness sector.
When did NeoImmuneTech. complete a stock split?▼
The last stock split for NeoImmuneTech. was on June 10, 2026 with a ratio of 1:5.
Where is NeoImmuneTech. headquartered?▼
NeoImmuneTech. is headquartered in Rockville, South Korea.